DaVita Inc (DVA) Company Profile & Statistics

DaVita Inc
DVA
(NYSE)
N/A
147.16
+0.02 (+0.01%)
in:usd•As of: May 31, 2024 15:59 UTC -4
Open
147.14
High
147.31
Low
144.47

About DaVita Inc

CEO

Javier J. Rodriguez

Headquarters

2000 16th street

denver, co 80202, united states

Auditor

KPMG LLP

Employees

70,000

Share Holders

6,687

Website

www.davita.com

Industry

medical or nursing services

Sector

health services

Company Overview

DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.

DaVita Inc Statistics

Valuation Measures

Market Capitalization ²	12.91B
Enterprise Value	21.60B
Enterprise Value/EBITDA (ttm)	8.54
Price to Earnings Ratio (ttm)	15.98
Price to Book (mrq)	11.36
Price to Sales (ttm)	1.04
Price to Cash (ytd)	8.73

Profitability

Gross Margin (ttm)	32.39%
Operating Margin (ttm)	6.89%
Profit Margin (ttm)	6.61%
Return on Equity (ttm)	68.52%
Return on Invested Capital (ttm)	11.16%
Return on Assets (ttm)	4.98%

Income Statement

Revenue (ttm)	12.34B
Revenue Per Share (ttm)	140.68
Gross Profit (ttm)	4.00B
EBITDA (ttm)³	2.53B
Net Income Avi to Common (ttm)	815.64M
Diluted EPS (ttm)	8.80

Share Statistics

Beta (5Y Monthly)	1.04
52-Week Change	55.38%
S&P500 52-Week Change	25.03%
S&P500 Member	Yes
Stock Optionable	Yes
Total Shares Outstanding ¹	87.70M
Dividend Yield	0.00%
Float ⁴	85.95M
% Held by Insiders	2.00%
% Held by Institutions	90.12%

Balance Sheet

Total Cash (mrq)	441.39M
Total Cash Per Share (mrq)	5.03
Total Debt (mrq)	9.13B
Total Debt/Equity (mrq)	806.01%
Current Ratio (mrq)	1.43%
Quick Ratio (mrq)	1.37%
Book Value Per Share (mrq)	12.91

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.49
Free Cash Flow (ytd)	-248.81M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

DaVita Inc

Trade With A Regulated Broker